Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amicus Therapeutics (FOLD)

Amicus Therapeutics (FOLD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Amicus Therapeutics Appoints Eiry W. Roberts, M.D. to its Board of Directors

Amicus Therapeutics (Nasdaq: FOLD), today announced the election and appointment of Eiry W. Roberts, M.D. to its Board of Directors. Dr. Roberts is an esteemed drug developer who brings approximately 30...

FOLD : 9.93 (-2.65%)
Why Is Amicus Therapeutics (FOLD) Up 8.1% Since Last Earnings Report?

Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

FOLD : 9.93 (-2.65%)
Amicus Therapeutics Announces United Kingdom's MHRA Grants Early Access to AT-GAA

Permits All Eligible Individuals with Late-Onset Pompe Disease Access to AT-GAA Prior to Marketing Authorization in the UK

FOLD : 9.93 (-2.65%)
Amicus Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the Goldman Sachs 42 Annual Global Healthcare Conference, being...

FOLD : 9.93 (-2.65%)
The Alliance for Artificial Intelligence in Healthcare Adds Google, Roche as Members to Advocate for Solutions to the World's Biggest Health Challenges

BALTIMORE, May 25, 2021

FOLD : 9.93 (-2.65%)
Amicus Therapeutics Announces Upcoming Presentations at the 16th International Congress on Neuromuscular Diseases

Amicus Therapeutics (Nasdaq: FOLD), today announced two posters for presentation highlighting its development program for Pompe disease at the 16th International Congress on Neuromuscular Diseases (ICNMD)...

FOLD : 9.93 (-2.65%)
Amicus' (FOLD) Q1 Loss Wider Than Expected, Sales Up Y/Y

Amicus (FOLD) reports a wider Q1 loss and sales miss estimates.

SNY : 52.86 (-0.71%)
RHHBY : 47.0800 (-0.86%)
FOLD : 9.93 (-2.65%)
TAK : 16.55 (-2.13%)
Amicus Therapeutics (FOLD) Reports Q1 Loss, Lags Revenue Estimates

Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -8.70% and -7.47%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

FOLD : 9.93 (-2.65%)
Amicus Therapeutics: Q1 Earnings Snapshot

CRANBURY, N.J. (AP) _ Amicus Therapeutics Inc. (FOLD) on Monday reported a loss of $65.7 million in its first quarter.

FOLD : 9.93 (-2.65%)
Amicus Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates

Galafold (migalastat) Performance Reflects Continued Strong Adoption in All Key Global Regions; On-Track to Achieve Revenue Guidance of $300M-$315M

FOLD : 9.93 (-2.65%)
Amicus Therapeutics to Present at Upcoming Investor Conferences in May 2021

Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in upcoming presentations at the following virtual investor conferences in May:

FOLD : 9.93 (-2.65%)
Amicus Therapeutics Appoints Sebastien Martel as Senior Vice President of Strategy and Business Development

Most Recently Served as Global Head of Rare Diseases at Sanofi Genzyme

FOLD : 9.93 (-2.65%)
Amicus Therapeutics Announces Upcoming Presentations at the American Society of Gene & Cell Therapy 24th Annual Meeting

Amicus Therapeutics (Nasdaq: FOLD), today announced the acceptance of two abstracts for presentation at the American Society of Gene & Cell Therapy 24th Annual Meeting being held virtually, May 11-14,...

FOLD : 9.93 (-2.65%)
Amicus Therapeutics (FOLD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Amicus Therapeutics (FOLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FOLD : 9.93 (-2.65%)
Amicus Therapeutics Announces Successful Pre-BLA Meeting with U.S. FDA for AT-GAA for the Treatment of Pompe Disease

Existing Data Support Regulatory Submissions

FOLD : 9.93 (-2.65%)
Amicus Therapeutics Recognized as a Great Place to Work(R) in Europe

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that it has been...

FOLD : 9.93 (-2.65%)
Amicus Therapeutics to Announce First Quarter 2021 Financial Results on May 10, 2021

Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Monday, May 10, 2021 at 8:30 a.m. ET to discuss financial results for the first...

FOLD : 9.93 (-2.65%)
Healthcare Systems Begin to Incorporate Live Streaming Capabilities

, /PRNewswire/ -- The global video streaming market size is anticipated to exhibit remarkable growth, owing to the advent and increasing popularity of digital video streaming worldwide. Video streaming,...

FOLD : 9.93 (-2.65%)
SJ : 6.40 (+3.73%)
CERN : 78.80 (-0.16%)
UNH : 389.37 (-2.01%)
ATVI : 91.49 (-1.82%)
VZ : 55.82 (-1.26%)
Global Fabry Disease Treatment Market Size Value Surges to Record USD 3.78 Billion by 2026: Facts & Factors

Facts and Factors have published a new research report titled "Fabry Disease Treatment Market by Drugs (Agalsidase Beta, Migalastat, and Pipeline Drugs), By Treatment (Enzyme Replacement Therapy (ERT),...

FOLD : 9.93 (-2.65%)
SHPG : 179.20 (+4.10%)
Thinking about buying stock in Grupo Televisa, Phunware, Immunitybio, Flexion Therapeutics, or Amicus Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TV, PHUN, IBRX, FLXN, and FOLD.

FLXN : 9.16 (-1.61%)
FOLD : 9.93 (-2.65%)
IBRX : 13.41 (-3.53%)
PHUN : 1.3000 (unch)
TV : 13.58 (-0.95%)

Barchart Exclusives

Lumber Prices See Record Drop Following Historic Highs
Lumber futures saw an 18% drop last week, its biggest drop in history.  With prices currently under $1,000 per thousand board feet, prices are down almost 41% since its record high in May. Even with a record breaking drop, prices are still significantly higher than pre pandemic prices.  According to... Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar